Abstract/References

Kallmann syndrome, a congenital disorder of idiopathic hypogonadotropic hypogonadism associated with anosmia, results in infertility because of anovulation. Assisted reproductive technology (ART) is considered when optimal ovulation induction therapy is difficult or when several cycles of ovulation induction therapy do not result in pregnancy. However, evidence is lacking regarding the optimal ART treatment for Kallmann syndrome. We report the case of a 33-year-old woman who successfully achieved pregnancy and delivery after ART treatment. At 29 years old, she was diagnosed with Kallmann syndrome due to hypothalamic amenorrhea and anosmia. At 33 years old, she revisited the hospital, desiring a child after one year of infertility. Due to anovulation, she was treated with gonadotropin therapy, but controlling follicular development was difficult, and thus ART treatment was initiated. The controlled ovarian stimulation (COS) protocol for ART treatment employed gonadotropins, recombinant follicular stimulating hormone/human menopausal gonadotropin plus human chorionic gonadotropin, to promote follicular growth. Four oocytes were retrieved, and two cleaved embryos were vitrified and cryopreserved. After vitrified-warmed embryo transfer of a morula stage embryo in a hormone replacement cycle, pregnancy was achieved but resulted in a miscarriage. A second oocyte retrieval was performed under the same COS; four oocytes were retrieved, and two cleaved embryos were vitrified and cryopreserved. Further, a pregnancy was achieved through the vitrified warmed embryo transfer. At 40 weeks and 6 days of gestation, a baby boy weighing 3,344 g with an Apgar score of 7/8 was delivered vaginally. The mother’s postpartum course and neonate were free from adverse events. For women with Kallmann syndrome, ART treatment and selective embryo cryopreservation may be a reasonable and safe option.

1. Bry-Gauillard H, Trabado S, Bouligand J, et al. Congenital hypogonadotropic hypogonadism in females:clinical spectrum, evaluation and genetics. Ann Endocrinol (Paris), 71:158-162, 2010.

2. Cadman SM, Kim SH, Hu Y, Gonzalez-Martinez D, Bouloux PM. Molecular pathogenesis of Kallmann’s syndrome. Horm Res, 67:231-242, 2007.

3. Young J, Xu C, Papadakis GE, et al. Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev, 40:669-710, 2019.

4. Dode C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet, 17:139-146, 2009.

5. Christou F, Pitteloud N, Gomez F. The induction of ovulation by pulsatile administration of GnRH:an appropriate method in hypothalamic amenorrhea. Gynecol Endocrinol, 33:598-601, 2017.

6. Battaglia C, Salvatori M, Regnani G, Giulini S, Primavera MR, Volpe A. Successful induction of ovulation using highly purified follicle-stimulating hormone in a woman with Kallmann’s syndrome. Fertil Steril, 73:284-286, 2000.

7. Martin KA, Hall JE, Adams JM, Crowley WF, Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab, 77:125-129, 1993.

8. Nakagawa K, Iwasaki W, Sato M, et al. Successful pregnancy, achieved by ovulation induction using a human menopausal gonadotropin low-dose step-up protocol in an infertile patient with Kallmann’s syndrome. J Obstet Gynaecol Res, 31:140-143, 2005.

9. Kousta E, White DM, Piazzi A, Loumaye E, Franks S. Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann’s syndrome. Hum Reprod, 11:70-71, 1996.

10. Sungurtekin U, Fraser IS, Shearman RP. Pregnancy in women with Kallmann’s syndrome. Fertil Steril, 63:494-499, 1995.

11. Aharoni A, Tal J, Paltieli Y, Porat N, Leibowitz Z, Sharf M. Kallmann syndrome:a case of twin pregnancy and review of the literature. Obstet Gynecol Surv, 44:491-494, 1989.

12. Chryssikopoulos A, Gregoriou O, Papadias C, Loghis C. Gonadotropin ovulation induction and pregnancies in women with Kallmann’s syndrome. Gynecol Endocrinol, 12:103-108, 1998.

13. Yu HT, Lee CL, Huang HY, Soong YK. Successful pregnancy in a woman with Kallmann’s syndrome using human menopausal gonadotropin followed by low-dose human chorionic gonadotropin in the mid-to-late follicular phase. Taiwan J Obstet Gynecol, 51:300-302, 2012.

14. Szilagyi A, Manfai Z, Kiesel L, Szabo I. Kallmann’s syndrome:pregnancy through intracytoplasmic sperm injection and complicated by gestational diabetes. Gynecol Endocrinol, 15:325-327, 2001.

15. Shimoda M, Iwayama H, Ishiyama M, Nakatani A, Yamashita M. Successful pregnancy by vitrified-warmed embryo transfer for a woman with Kallmann syndrome. Reprod Med Biol, 15:45-49, 2016.

16. Nishiyama R, Kitaya K, Takaya Y, et al. Successful ongoing pregnancy following cryopreserved-thawed blastocyst transfer in an infertile Kallmann syndrome woman with balanced reciprocal translocation: a case report. Clin Exp Obstet Gynecol, 46:331-332, 2019.

17. Organization WH. WHO laboratory manual for the examination and processing of human semen. Geneva, Switzerland, 2010.

18. Tao J, Tamis R, Fink K, Williams B, Nelson-White T, Craig R. The neglected morula/compact stage embryo transfer. Hum Reprod, 17:1513-1518, 2002.

19. Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod, 9:1237-1242, 1994.

20. Raju GA, Chavan R, Deenadayal M, et al. Luteinizing hormone and follicle stimulating hormone synergy:A review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci, 6:227-234, 2013.

21. Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism**Supported by Organon International, Oss, The Netherlands. Fertil Steril, 59:738-742, 1993.

22. Ben-Chetrit A, Gotlieb L, Wong PY, Casper RF. Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women:examination of the two cell, two gonadotropin theory. Fertil Steril, 65:711-717, 1996.

23. Ulug U, Ben-Shlomo I, Tosun S, Erden HF, Akman MA, Bahceci M. The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program. J Assist Reprod Genet, 22:167-171, 2005.

24. Kumbak B, Kahraman S. Women with hypogonadotropic hypogonadism:cycle characteristics and results of assisted reproductive techniques. Acta Obstet Gynecol Scand, 85:1453-1457, 2006.

25. doYildirim G, Ficicioglu C, Attar R, Akcin O, Tecellioglu N. Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal factor infertility. Clin Exp Obstet Gynecol, 37:120-122, 2010.

26. Caragia A, Vlismas A, Pepas L, Mohamed M, Tozer A, Sabatini L. ART and pregnancy outcome in hypogonadotrophic hypogonadism patients compared to matched controls. Fertil Steril, 98:S286, 2012.

27. Ghaffari F, Arabipoor A, Lankarani NB, Etminan Z, Tehraninejad ES. Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women. Ann Saudi Med, 33:235-240, 2013.

28. Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci, 8:146-150, 2015.

29. Mumusoglu S, Ata B, Turan V, et al. Does pituitary suppression affect live birth rate in women with congenital hypogonadotrophic hypogonadism undergoing intra-cytoplasmic sperm injection? A multicenter cohort study. Gynecol Endocrinol, 33:728-732, 2017.

30. Kuroda K, Ezoe K, Kato K, et al. Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism. J Obstet Gynaecol Res, 44:922-928, 2018.

31. Yilmaz S, Ozgu-Erdinc AS, Yumusak O, Kahyaoglu S, Seckin B, Yilmaz N. The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization. Syst Biol Reprod Med, 61:228-232, 2015.

32. Gao Y, Yu B, Mao J, Wang X, Nie M, Wu X. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients:a systematic review and meta-analysis. BMC Endocr Disord, 18:85, 2018.